Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB5 vs Humira in Moderate to Severe Rheumatoid Arthritis
NCT02167139Phase 3Completed
- Sponsor
- Samsung Bioepis
- Start
- May 2014
- Primary completion
- Apr 2015
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of adalimumab in rheumatoid arthritis (RA), sponsored by Samsung Bioepis. Started May 2014; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02167139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02167139.